We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-2.76%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$754M
AUM Growth
+$87.8M
Cap. Flow
+$160M
Cap. Flow %
21.21%
Top 10 Hldgs %
3.31%
Holding
2,028
New
691
Increased
437
Reduced
328
Closed
568

Sector Composition

Rank Sector Weight
1 Healthcare 16.63%
2 Consumer Discretionary 15.71%
3 Technology 14.34%
4 Industrials 12%
5 Financials 11.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SJT
1276
San Juan Basin Royalty Trust
SJT
$118M
$171K 0.02%
18,147
-8,539
-32% -$100K
LXRX icon
1277
Lexicon Pharmaceuticals
LXRX
$1.1B
$170K 0.02%
71,004
-300,594
-81% -$832K
DADA
1278
DELISTED
Dada Nexus
DADA
$166K 0.02%
35,114
-18,900
-35% -$125K
AHRT
1279
AH Realty Trust
AHRT
$517M
$162K 0.02%
15,645
+5,460
+54% +$71.3K
YALA
1280
Yalla Group
YALA
$832M
$162K 0.02%
49,889
-8,203
-14% -$33.5K
SOL
1281
DELISTED
Emeren Group
SOL
$159K 0.02%
31,551
-27,132
-46% -$155K
AFMD
1282
DELISTED
Affimed
AFMD
$157K 0.02%
7,616
-1,741
-19% -$48.4K
MLKN icon
1283
MillerKnoll
MLKN
$1.67B
$157K 0.02%
+10,037
New +$276K
TFSL icon
1284
TFS Financial
TFSL
$4.93B
$157K 0.02%
12,042
-14,485
-55% -$205K
GGB icon
1285
Gerdau
GGB
$9.7B
$156K 0.02%
43,457
+22,904
+111% +$83.2K
GLUE icon
1286
Monte Rosa Therapeutics
GLUE
$1.35B
$156K 0.02%
+19,084
New +$175K
VIPS icon
1287
Vipshop
VIPS
$7.53B
$155K 0.02%
18,471
+3,092
+20% +$30.8K
AKBA icon
1288
Akebia Therapeutics
AKBA
$252M
$154K 0.02%
+486,568
New +$191K
ALXO icon
1289
ALX Oncology
ALXO
$290M
$154K 0.02%
+16,114
New +$188K
BB icon
1290
BlackBerry
BB
$5.26B
$153K 0.02%
32,456
-22,874
-41% -$137K
FPI
1291
Farmland Partners
FPI
$432M
$153K 0.02%
12,073
-23,250
-66% -$331K
SMRT icon
1292
SmartRent
SMRT
$272M
$153K 0.02%
+67,421
New +$266K
BCOV
1293
DELISTED
Brightcove, Inc.
BCOV
$153K 0.02%
+24,338
New +$158K
HOUS
1294
DELISTED
Anywhere Real Estate
HOUS
$152K 0.02%
18,687
-15,738
-46% -$161K
BRDG
1295
DELISTED
Bridge Investment Group
BRDG
$151K 0.02%
10,418
-1,860
-15% -$30.1K
INVZ icon
1296
Innoviz Technologies
INVZ
$112M
$151K 0.02%
+28,961
New +$139K
SLQT icon
1297
SelectQuote
SLQT
$121M
$151K 0.02%
206,609
+176,401
+584% +$293K
UTZ icon
1298
Utz Brands
UTZ
$1.25B
$151K 0.02%
10,002
-25,986
-72% -$421K
ABSI icon
1299
Absci
ABSI
$1.51B
$149K 0.02%
47,648
-6,335
-12% -$23.3K
SABR icon
1300
Sabre
SABR
$835M
$149K 0.02%
28,890
-40,821
-59% -$272K

Similar funds

GSA Capital Partners's Q3 2022 Portfolio in Review

As of Q3 2022, GSA Capital Partners held 2,028 positions worth $754M, up 13% from $666M the previous quarter. Its ten largest holdings account for 3.3% of the portfolio.

GSA Capital Partners deployed $160M of net new capital in Q3 2022, opening 691 new positions and adding to 437 existing holdings. Its largest new stake was Dave & Buster's: 75,954 shares worth $2.36M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Genpact, an estimated $3.61M trimmed.

  • GSA Capital Partners's largest Q3 2022 buy was Dave & Buster's: 75,954 shares worth $2.36M.
  • GSA Capital Partners added most to Grocery Outlet in Q3 2022, an estimated $2.54M increase.
  • GSA Capital Partners's biggest Q3 2022 reduction was Genpact, cutting an estimated $3.61M.
  • GSA Capital Partners fully exited Relay Therapeutics in Q3 2022, selling an estimated $2.99M.
  • GSA Capital Partners's ten largest holdings make up 3.3% of its $754M portfolio in Q3 2022.
  • GSA Capital Partners opened 691 new positions and closed 568 in Q3 2022.
  • GSA Capital Partners's portfolio value rose 13% quarter-over-quarter to $754M.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.